Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab.
Kazutaka NakamuraYudai IshiyamaYuki NemotoHiroki IshiharaHidekazu TachibanaHironori FukudaHiroaki ShinmuraYasunobu HashimotoKazuhiko YoshidaJunpei IizukaHideki IshidaTsunenori KondoToshio TakagiPublished in: International journal of clinical oncology (2023)
LIPI, a simple and convenient score, could be a significant prognostic biomarker of OS, PFS, and DCRs for mUC treated with pembrolizumab.